Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Platelets play a key role in the immune system and their lifespan and aging are important for developing new treatments.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Immune cells are crucial for hair growth and preventing hair loss.

Abnormal ECM and immune cell interactions can cause skin diseases.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

The skin's immune system helps it regenerate and fight infections.

Histocultures help personalize cancer treatments, study hair growth, and explore immune responses.

Non-immune factors play a significant role in alopecia areata.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

A targetoid hair regrowth pattern indicates recovery in alopecia areata.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Upadacitinib improved multiple immune-related conditions in one patient.

MEG3-miRNAs help control wool traits in young Tan sheep by regulating immune responses, but their decline with age leads to wool changes.